Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07525791 · ClinicalTrials.gov registry record · Phase 1
A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
A Phase 1 study, sponsored by Novo Nordisk A/S.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT07525791 is a Phase 1 study that is actively recruiting participants, run by Novo Nordisk A/S. The registered enrollment target is 45 participants.
The verdict
NCT07525791, a Phase 1 study, is actively recruiting participants, sponsored by Novo Nordisk A/S.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to find out if NNC0662-0419 is safe and effective to be taken together with other medicines, like birth control pills, and emptying of the stomach in women not able to become pregnant living with overweight or obesity. There are 3 study treatments in this study, participants will get all of the treatments, NNC0662-0419 the treatment being tested, Altavera a type of birth control pill, Acetaminophen a common type of mild painkiller.
Interventions
- DRUG Acetaminophen
- DRUG NNC0662-0419
- DRUG Oral contraceptive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-04-07 |
| Est. Completion | 2027-05-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07525791
The ClinicalTrials.gov registry entry for NCT07525791 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acetaminophen is the first listed.
NCT07525791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07525791 about?
NCT07525791 is a clinical study titled "A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight". The purpose of this clinical study is to find out if NNC0662-0419 is safe and effective to be taken together with other medicines, like birth control pills, and emptying of the stomach in women not able to become pregnant living with overweight or obesity. There are 3 study treatments in this study,...
What is the current status of trial NCT07525791?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2026-04-07. Estimated completion is 2027-05-04.
What interventions are being tested in trial NCT07525791?
The interventions under investigation include: Acetaminophen (DRUG), NNC0662-0419 (DRUG), Oral contraceptive (DRUG).
Who is sponsoring clinical trial NCT07525791?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.